|
||||||||||||||||||
| Helping pharmacy & health communities improve access to Emergency Contraception (EC) |
 |
|
|||||||
|
EC PHARMACY UPDATEThere is currently no known activity promoting direct pharmacy access to EC. The state legislature is very conservative. The Idaho Women's Health Coalition surveyed hospitals in Fall 2002 to determine access to EC for rape survivors. Organizations that are positioned to provide leadership around EC include: Planned Parenthood, American Civil Liberties Union (ACLU), Idaho Women's Network, Boise State Women's Center, and Idaho Access.
CONTACTSKris Jonas Susan Ault Ellie Merrick Marty Durand
USEFUL LINKSIdaho Board of Pharmacy Idaho State Pharmacy Association Idaho Legislature
PROTOCOL ENVIRONMENTPossible Environment: Revision to Existing Authority Required This state permits collaborative practice agreements or a similar agreement between physicians and pharmacists. However, some modification of existing statutes and/or regulations is required to allow pharmacists to initiate EC for the general community. Pharmacist initiation of EC would require:
PHARMACY PRACTICE ACTPharmacy Practice Act Regulatory and Statutory Authority Note: The text presented below has been prepared by the American Pharmacists Association for the Pharmacy Access Partnership and reflects legislation or regulation promulgated as of June 15, 2003. IDAHO A pharmacist or group of pharmacists in any practice setting may initiate, modify and manage drug therapy pursuant to patient-specific collaborative practice agreements with one or more prescribing practitioners. The physician must refer the patient to the pharmacist and document such information in the patient medical chart. The pharmacist must keep the patient-specific protocol on file at the practice site. The parties must review the agreement at least once per year. The scope of practice is outlined in the protocol and may include any disease state listed. Under collaborative agreements, pharmacists may also collect and review patient drug histories, check vital signs, and order and evaluate lab tests directly related to drug therapy. The patient-specific collaborative agreement must identify the types of drug-related decisions the pharmacist is permitted to make and define how the prescriber will monitor pharmacist compliance and outcomes. It “may” also include, most notably:
Because the practice of pharmacy specifically includes “drug administration” and other “acts and services necessary to provide pharmaceutical care,” pharmacists in non-institutional settings may administer emergency contraceptives, immunizations and other injectable medications, to individual patients referred by the practitioner and pursuant to a patient-specific protocol. Pharmacists may also administer drugs (including emergency contraceptives and immunizations) in institutions, such as hospitals and nursing homes, under orders of the appropriate in-house staff and pursuant to a policy approved by the institution. Statutory authority: Provided in definitions of “practice of pharmacy” and “pharmaceutical care,” Idaho Code §§ 54-1704, -05 Regulatory authority: Provided in Board of Pharmacy regulations governing Collaborative Practice, Pharmacy Practice in Institutions, and Administration of Drugs, Idaho Admin. Code §§ 27.01.01-165, 252, and 256
IDAHO STATUTES TITLE 54 PROFESSIONS, VOCATIONS, AND BUSINESSES CHAPTER 17 PHARMACISTS 54-1704. PRACTICE OF PHARMACY. “Practice of pharmacy” means the interpretation, evaluation and dispensing of prescription drug orders; participation in drug and device selection, drug administration, drug regimen reviews and drug or drug-related research; provision of patient counseling and the provision of those acts or services necessary to provide pharmaceutical care; and the responsibility for: compounding and labeling of drugs and devices (except labeling by a manufacturer, repackager or distributor of nonprescription drugs and commercially packaged legend drugs and devices); proper and safe storage of drugs and devices, and maintenance of proper records for them; and the offering or performing of those acts, services, operations or transactions necessary to the conduct, operation, management and control of pharmacy. 54-1705. DEFINITIONS .… (21) “Pharmaceutical care” means drug therapy and other pharmaceutical patient care services intended to achieve outcomes related to the cure or prevention of a disease, elimination or reduction of a patient's symptoms, or arresting or slowing of a disease process as defined in the rules of the board.
IDAHO REGULATIONS IDAHO ADMINISTRATIVE CODE TITLE 01 - Chapter 01 IDAPA 27 - IDAHO STATE BOARD OF PHARMACY 27.01.01 - RULES OF THE IDAHO STATE BOARD OF PHARMACY 165. PHARMACOTHERAPY. Collaborative practice between pharmacists and prescribing practitioners is allowed as provided in this rule. (7-1-99) 01. Definitions. (7-1-99) a. Agreement. Means a written and signed agreement between a pharmacist or group of pharmacists and a prescribing practitioner or group of prescribing practitioners that provides for collaborative practice for the purpose of drug therapy management of patients. (7-1-99) b. Collaborative practice. Means a practice in which the prescribing practitioner makes a diagnosis, maintains ongoing supervision of patient care and refers the patient to a pharmacist, who may initiate and modify drug therapy management within the protocol established by the prescribing practitioner and the pharmacist. (7-1-99) c. Drug therapy management. Means the review of drug therapy regimen(s) of patients by a pharmacist for the purpose of evaluating and rendering advice to the prescribing practitioner regarding adjustment of the regimen. “Drug therapy management” includes: (7-1-99)
d. Prescribing practitioner. Means a practitioner in active practice duly authorized and recognized by law in Idaho to prescribe legend drugs and controlled substances. (7-1-99) e. Pharmacist’s scope of practice. Means those duties and limitations of duties placed upon a pharmacist by the collaborating practitioner, the Board, and applicable law, and includes the limitations implied by the specialty practiced by the collaborating practitioner. (7-1-99) 02. Collaborative Practice Agreement. A pharmacist planning to engage in collaborative practice shall have on file at his or her place of practice a written agreement. The agreement may allow the pharmacist, within the pharmacist’s scope of practice, to conduct a drug therapy management which must be approved by a prescribing practitioner. The collaboration that the prescribing practitioner agrees to conduct with the pharmacist must be within the scope of the prescribing practitioner’s current practice. (7-1-99) 03. Contents Of Agreement. The agreement shall include: (7-1-99) a. A statement identifying the prescribing practitioners and the pharmacists who are a party to the agreement; (7-1-99) b. A statement of the types of drug therapy management decisions that the pharmacist is allowed to make, which may include: (7-1-99)
c. A method for the prescribing practitioner to monitor compliance with the agreement and clinical outcomes where drug therapy management by the pharmacist has occurred and to intercede where necessary; (7-1-99) d. A provision that allows the prescribing practitioner to override the agreement whenever he or she deems it necessary or appropriate; and (7-1-99) e. The agreement must be coupled with specific orders from the prescribing practitioner to apply such agreement as drug therapy management to any particular patient. The order must constitute a valid drug order or a valid prescription and contain all information necessary to conform to such requirements. (7-1-99) 04. Review, Renewal, And Revision Of Agreement. At a minimum, the written agreement shall be reviewed and renewed, and if necessary, revised every year. (7-1-99) 256. ADMINISTRATION OF DRUGS. 01. Administration Of Drugs. Drugs shall be administered at an institutional facility only upon the orders of those members of the medical staff who have been granted clinical privileges or who are authorized members of the house staff and by authorized licensed facility personnel in accordance with policies and procedures specified by the appropriate committee of the facility under applicable law and rules and by usual and customary standards of good medical practice. (7-1-93) 02. Self-Administration Of Drugs By Patients. Self-administration of drugs by patients shall be permitted only when specifically authorized by the treating or ordering physician, provided however, the patient has been educated and trained in the proper manner of self-administration and there is no risk of harm to the patient. (7-1-93)
|
